Agreement between commercially available ELISA and in-house Luminex SARS-CoV-2 antibody immunoassays

Serological diagnostic of the severe respiratory distress syndrome coronavirus 2 (SARS-CoV-2) is a valuable tool for the determination of immunity and surveillance of exposure to the virus. In the context of an ongoing pandemic, it is essential to externally validate widely used tests to assure corr...

Descripción completa

Detalles Bibliográficos
Autores principales: Santano, Rebeca, Barrios, Diana, Crispi, Fàtima, Crovetto, Francesca, Vidal, Marta, Chi, Jordi, Izquierdo, Luis, Gratacós, Eduard, Moncunill, Gemma, Dobaño, Carlota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460676/
https://www.ncbi.nlm.nih.gov/pubmed/34556736
http://dx.doi.org/10.1038/s41598-021-98296-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460676/
https://www.ncbi.nlm.nih.gov/pubmed/34556736
http://dx.doi.org/10.1038/s41598-021-98296-y

Ejemplares similares